Patents by Inventor David Laurence VAUX

David Laurence VAUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180117110
    Abstract: The present invention provides a method of treating cancer in a subject wherein the method comprising administering to the subject an IAP antagonist and a p38 and/or a MK2 inhibitor.
    Type: Application
    Filed: October 3, 2014
    Publication date: May 3, 2018
    Applicant: THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
    Inventors: Najoua LALAOUI, John Henry SILKE, David Laurence VAUX
  • Patent number: 9861679
    Abstract: The present invention provides a method of treating cancer in a subject wherein the method comprising administering to the subject an IAP antagonist and a p38 and/or a MK2 inhibitor.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: January 9, 2018
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Najoua Lalaoui, John Henry Silke, David Laurence Vaux
  • Publication number: 20160184383
    Abstract: The present invention provides a method of treating cancer in a subject wherein the method comprising administering to the subject an IAP antagonist and a p38 and/or a MK2 inhibitor.
    Type: Application
    Filed: October 5, 2015
    Publication date: June 30, 2016
    Applicant: THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
    Inventors: Najoua LALAOUI, John Henry SILKE, David Laurence VAUX